SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (2466)4/19/1997 12:37:00 PM
From: paul goldstein   of 4342
 
rick, maybe i can add a little thought to the process ..
in february, babish and koch did not want to get a new ceo
babish wanted the job , but, to do it, he had to make an
attempt to give it to someone else.
so they interviewed and interviewed . just think, they had
to say, yes, and one was hired! but, nope, they delayed, not keith..
as to producr rollout. it was john babish and kochs who were the
ones that decided to delay the roll out and to give it to
east west to handle. i think it was a good idea, but, it caused
delays.
now as this fda story.. now it may rain, snow, or sun shine next
thursday, but i can't say for sure it will not do all three or
even do different.my point? the fda is not involved at this time
with the products.yes they can . but, they are not holding
up or effecting production.
the laeling and all the packaging is done by east west and they
have done this before and its common to them.
i think the thinking has to go back to what are the products,
the possibility of going foward and the time frames.
as to all these clinical trials..
hank can answer this better. but, here goes from me<grin>
if they proceed with additional trials they get caught up in
needing fda approvals and cannot sell them as natural
products under that "act".
so they must sell them first in the market place, then proceed to
the long , grueling, fda route.
r4emeber, natural products generate sales and profits.
fda route burns cash and no profits. for years
as to a sales or financial or a research, or anyone else.
they are all rentable and all can and will do the job.
look at the board of directors. between them, the know
hundreds if not thousands of candidates for any position
prln wants filled.
keith rhodes? he know the company. was the leader for yers.
he has the backing of the serious investors and the board.
remember folks, boards run companies any way they like if
they have the control. they have the control..there are no
contenders left.
so button down the hatch, sink, and learn to swim and see the
surface again. or, something like that.
stock price is terrible.
objectives still on target.
cash..almost three million .. more available if needed.
its not needed.
as to the east west deal.. prln has a contract for one
year to launch products and paid them 200 thousand dollars for
this.
then they loaned east west lots of money that would have to be
repaid and they do not want it back. they want in on this deal.
remember, east west is doing all the marketing..everything..
hope i helped in the thinking process. we will have other thoughts
as we all have our different needs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext